Biopharmaceuticals
GTC Biotherapeutics Reports Second Quarter 2007 Financial Results
Published in Drug Law Weekly, August 21st, 2007
GTC Biotherapeutics, Inc. ("GTC", Nasdaq: GTCB) reported today its financial results for the second quarter ended July 1, 2007. The total net loss for the quarter was $10.6 million, or $0.14 per share, compared with $9.1 million, or $0.15 per share, in the second quarter of 2006. The total net loss for the first six months of 2007 was $18.1 million, or $0.23 per share, compared to $17.6 million, or $0.29 per share, for the first six months of 2006.
"Our European partner for ATryn(R), LEO Pharma A/S, has made good progress in the quarter in introducing the product to the physician community in Europe for the hereditary deficiency indication while also initiating the...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
Source: Drug Law Weekly (2007-08-21)
More Articles from Drug Law Weekly
- Bioengineering
Point Therapeutics Reports Second Quarter 2007 Financial Results - Biotechnology Business
Biovail Enters Into License and Development Agreement - Biotechnology Business
DUSA Pharmaceuticals Reports Second Quarter 2007 Corporate Highlights and Financial Results - Chemicals
Abraxis BioScience Acquires from the Buck Institute Exclusive Worldwide Intellectual Property Rights for Technologies Designed to Discover New Drug Candidates - Clinical Trial Research
Cutera Reports Second Quarter 2007 Results - Clinical Trial Research
Oculus Innovative Sciences Announces $10.1 Million Private Placement of Common Stock - More from this issue of Drug Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
